MARKET

PERCF

PERCF

Percheron Therapeutics
OTCPK
0.0020
NaN%
Closed 09:30 06/26 EDT
OPEN
--
PREV CLOSE
0.0020
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.010
52 WEEK LOW
0.0020
MARKET CAP
3.04M
P/E (TTM)
-0.3704
1D
5D
1M
3M
1Y
5Y
1D
Percheron Completes Manufacture of HMBD-002 Drug Substance for 2026 Trial
TipRanks · 06/16 22:56
Percheron Therapeutics Issues New Tranche of Unquoted Equity Securities
TipRanks · 06/01 05:55
Percheron Therapeutics Plans Issue of 13.75 Million Options to Bolster Capital
TipRanks · 05/29 01:33
WHO assigns proposed nonproprietary name to Percheron’s cancer drug HMBD-002
TipRanks · 05/26 00:19
Percheron Therapeutics Updates Market on Lapse of 600,000 Options
TipRanks · 04/30 23:23
Percheron Therapeutics Issues 131 Million Unquoted Options at $0.01 Exercise Price
TipRanks · 04/21 23:43
Percheron Therapeutics Seeks ASX Quotation for 262.9 Million New Shares
TipRanks · 04/21 23:29
Percheron’s VISTA-Targeting Cancer Drug Clears Key Phase I Safety Hurdle
TipRanks · 04/20 22:45
More
About PERCF
Percheron Therapeutics Limited is an Australia-based biotechnology company. The Company is focused on the development and commercialization of novel therapies for oncology and rare diseases. The Company’s lead program is HMBD-002, a monoclonal antibody targeting the immune checkpoint regulator, VISTA. HMBD-002 has completed a phase I clinical trial in patients with advanced cancer. HMBD-002 is a recombinant humanized monoclonal IgG4 antibody to human v-domain immunoglobulin suppressor of T-cell activation (VISTA). VISTA is one of a number of novel immuno-oncology targets under investigation by pharmaceutical companies, with potential applications to a range of solid tumors and hematological malignancies.

Webull offers Percheron Therapeutics Ltd stock information, including OTCPK: PERCF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PERCF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PERCF stock methods without spending real money on the virtual paper trading platform.